Regeneron Pharmaceuticals, Inc.
2020 Q1 - 2026 Q1 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 842 | 0.0% | 1,090 | 3/31/2026 |
| 2025 Q4 | 5/14/2026 | 916 | 0.0% | 1,187 | 12/31/2025 |
| 2025 Q3 | 5/15/2026 | 556 | 0.0% | 989 | 9/30/2025 |
| 2025 Q2 | 5/15/2026 | 539 | 0.0% | 1,026 | 6/30/2025 |
| 2025 Q1 | 5/19/2026 | 653 | 0.0% | 1,029 | 3/31/2025 |
| 2024 Q4 | 6/12/2026 | 591 | 0.0% | 829 | 12/31/2024 |
| 2024 Q3 | 6/12/2026 | 849 | 0.0% | 808 | 9/30/2024 |
| 2024 Q2 | 6/12/2026 | 863 | 0.0% | 821 | 6/30/2024 |
| 2024 Q1 | 6/12/2026 | 788 | 0.0% | 819 | 3/31/2024 |
| 2023 Q4 | 6/12/2026 | 674 | 0.0% | 767 | 12/31/2023 |
| 2023 Q3 | 6/12/2026 | 709 | 0.0% | 862 | 9/30/2023 |
| 2023 Q2 | 6/12/2026 | 510 | 0.0% | 710 | 6/30/2023 |
| 2023 Q1 | 6/12/2026 | 575 | 0.0% | 700 | 3/31/2023 |
| 2022 Q4 | 6/12/2026 | 553 | 0.0% | 767 | 12/31/2022 |
| 2022 Q3 | 6/12/2026 | 390 | 0.0% | 566 | 9/30/2022 |
| 2022 Q2 | 6/12/2026 | 335 | 0.0% | 566 | 6/30/2022 |
| 2022 Q1 | 6/12/2026 | 418 | 0.0% | 598 | 3/31/2022 |
| 2021 Q4 | 6/15/2026 | 342 | 0.0% | 542 | 12/31/2021 |
| 2021 Q3 | 6/15/2026 | 475 | 0.0% | 785 | 9/30/2021 |
| 2021 Q2 | 6/15/2026 | 313 | 0.0% | 561 | 6/30/2021 |
| 2021 Q1 | 6/15/2026 | 289 | 0.0% | 611 | 3/31/2021 |
| 2020 Q4 | 6/15/2026 | 290 | 0.0% | 601 | 12/31/2020 |
| 2020 Q3 | 6/15/2026 | 336 | 0.1% | 601 | 9/30/2020 |
| 2020 Q2 | 6/15/2026 | 710 | 0.2% | 1,139 | 6/30/2020 |
| 2020 Q1 | 6/15/2026 | 394 | 0.1% | 807 | 3/31/2020 |